Market Cap 5.61M
Revenue (ttm) 360,000.00
Net Income (ttm) -14.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,955.56%
Debt to Equity Ratio 0.00
Volume 165,300
Avg Vol 455,820
Day's Range N/A - N/A
Shares Out 25.48M
Stochastic %K 34%
Beta 0.79
Analysts Strong Sell
Price Target $8.00

Company Profile

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral di...

Industry: Biotechnology
Sector: Healthcare
Phone: 631 760 8100
Address:
40 Marcus Drive, Suite 1, Melville, United States
MGroup
MGroup Aug. 17 at 4:44 PM
$BRTX Seems no good news out of this one. And they are not answering any questions at corporate or returning phone calls. I think something from the new management is in order. What a fukn mess this has become. It seemed like we were finally on our way and now this mess. Been in this stock since February 2019 and I'm beyond livid.
1 · Reply
Dsradoff720
Dsradoff720 Aug. 12 at 6:13 PM
$BRTX So this is something that does concern me (lender board nominee section) but the dates have come and gone already with no offering. Does that mean the board members automatically resigned as if the 10th? I think what happened is they got a waiver since the lender already controls the board. We would know by now if there was an offering consumated. It seems like the same language used in other contacts they had like shuttle pharmaceutical. This is such a wildcard stock lol it will either go to 0 or the moon!
2 · Reply
TheBigDawgRoman
TheBigDawgRoman Aug. 11 at 8:05 PM
$BRTX bag holding at 52
0 · Reply
Lyn30
Lyn30 Aug. 11 at 4:39 AM
$BRTX Every penny board one idiot is must 😂 . In this board one below 👇 😂. Resident bear I always block idiots
1 · Reply
Tuskdog
Tuskdog Aug. 10 at 5:46 PM
$BRTX so what’s the September date that they have to do a reverse split? 
1 · Reply
Lyn30
Lyn30 Aug. 10 at 5:14 PM
$BRTX This one may run big soon imo
1 · Reply
Zephix
Zephix Aug. 9 at 11:06 PM
$BRTX The company completed treatment administration in 99 patients in a randomized, double-blind, sham-controlled Phase 2 trial for chronic lumbar disc disease. Topline safety/efficacy data are expected in Q2 2027...
0 · Reply
MGroup
MGroup Aug. 3 at 9:56 PM
$BRTX it was all so positive for most of this year. Then the bottom dropped out. I'm ready to wrap up this "investment"
2 · Reply
Dsradoff720
Dsradoff720 Aug. 3 at 3:14 PM
$BRTX we need some bombshell good news dropped soon!
1 · Reply
TheBigDawgRoman
TheBigDawgRoman Jul. 31 at 4:04 PM
$BRTX lol
0 · Reply
Latest News on BRTX
BioRestorative Therapies completes manufacturing for BRTX-100

2026-06-25T12:20:21.000Z - 7 weeks ago

BioRestorative Therapies completes manufacturing for BRTX-100


BioRestorative Therapies Slides: Corporate presentation

Jun 25, 2026, 7:00 AM EDT - 7 weeks ago

BioRestorative Therapies Slides: Corporate presentation


BioRestorative Therapies Slides: Corporate presentation

Jun 3, 2026, 7:00 AM EDT - 2 months ago

BioRestorative Therapies Slides: Corporate presentation


BioRestorative Therapies completes Phase 2 dosing of BRTX-100

2026-05-26T16:05:13.000Z - 3 months ago

BioRestorative Therapies completes Phase 2 dosing of BRTX-100


BioRestorative Therapies Quarterly report: Q1 2026

May 14, 2026, 4:00 PM EDT - 3 months ago

BioRestorative Therapies Quarterly report: Q1 2026


BioRestorative Therapies Slides: Corporate presentation

Apr 24, 2026, 7:00 AM EDT - 4 months ago

BioRestorative Therapies Slides: Corporate presentation


BioRestorative Therapies Proxy statement: Proxy filing

Apr 13, 2026, 8:00 AM EDT - 4 months ago

BioRestorative Therapies Proxy statement: Proxy filing


BioRestorative Therapies Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 4 months ago

BioRestorative Therapies Proxy statement: Proxy filing


BioRestorative Therapies Annual report: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 5 months ago

BioRestorative Therapies Annual report: Q4 2025


BioRestorative Therapies issues letter to shareholders

2026-03-04T13:33:10.000Z - 5 months ago

BioRestorative Therapies issues letter to shareholders


BioRestorative Announces Closing of $5.0 Million Public Offering

Feb 13, 2026, 8:30 PM EST - 6 months ago

BioRestorative Announces Closing of $5.0 Million Public Offering


BioRestorative Announces Pricing of $5.0 Million Public Offering

Feb 11, 2026, 10:30 PM EST - 6 months ago

BioRestorative Announces Pricing of $5.0 Million Public Offering


BioRestorative Therapies files to sell 9.71M units

2026-02-09T22:40:19.000Z - 6 months ago

BioRestorative Therapies files to sell 9.71M units


BioRestorative Therapies Slides: Investor presentation

Nov 22, 2025, 7:00 AM EST - 9 months ago

BioRestorative Therapies Slides: Investor presentation


BioRestorative Therapies Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 9 months ago

BioRestorative Therapies Earnings Call Transcript: Q3 2025


BioRestorative Therapies Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 9 months ago

BioRestorative Therapies Quarterly report: Q3 2025


BioRestorative Therapies Earnings release: Q3 2025

Nov 12, 2025, 4:30 PM EST - 9 months ago

BioRestorative Therapies Earnings release: Q3 2025


BioRestorative Therapies Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Earnings Call Transcript: Q2 2025


BioRestorative Therapies Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Quarterly report: Q2 2025


BioRestorative Therapies Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Earnings release: Q2 2025


BioRestorative Therapies Proxy statement: Proxy Filing

Aug 8, 2025, 8:00 AM EDT - 1 year ago

BioRestorative Therapies Proxy statement: Proxy Filing


BioRestorative Therapies Transcript: Status Update

Jun 18, 2025, 10:50 AM EDT - 1 year ago

BioRestorative Therapies Transcript: Status Update


BioRestorative Announces Share Repurchase Program

Jun 17, 2025, 9:25 AM EDT - 1 year ago

BioRestorative Announces Share Repurchase Program


BioRestorative Therapies Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Earnings Call Transcript: Q1 2025


BioRestorative Therapies Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Quarterly report: Q1 2025


BioRestorative Therapies Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Earnings release: Q1 2025


BioRestorative Therapies Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Earnings Call Transcript: Q4 2024


BioRestorative Therapies Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Annual report: Q4 2024


BioRestorative Therapies Earnings release: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

BioRestorative Therapies Earnings release: Q4 2024


BioRestorative Therapies Transcript: Status Update

Feb 27, 2025, 10:30 AM EST - 1 year ago

BioRestorative Therapies Transcript: Status Update


BioRestorative Therapies Press release: Status Update

Feb 27, 2025, 10:30 AM EST - 1 year ago

BioRestorative Therapies Press release: Status Update


BioRestorative Therapies Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

BioRestorative Therapies Earnings Call Transcript: Q3 2024


BioRestorative Therapies Earnings release: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

BioRestorative Therapies Earnings release: Q3 2024


BioRestorative Therapies Quarterly report: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

BioRestorative Therapies Quarterly report: Q3 2024


BioRestorative Therapies Quarterly report: Q2 2024

Aug 13, 2024, 10:00 AM EDT - 2 years ago

BioRestorative Therapies Quarterly report: Q2 2024


BioRestorative Therapies Earnings release: Q2 2024

Aug 13, 2024, 10:00 AM EDT - 2 years ago

BioRestorative Therapies Earnings release: Q2 2024


BioRestorative Therapies Proxy statement: Proxy Filing

Aug 8, 2024, 8:00 AM EDT - 2 years ago

BioRestorative Therapies Proxy statement: Proxy Filing


MGroup
MGroup Aug. 17 at 4:44 PM
$BRTX Seems no good news out of this one. And they are not answering any questions at corporate or returning phone calls. I think something from the new management is in order. What a fukn mess this has become. It seemed like we were finally on our way and now this mess. Been in this stock since February 2019 and I'm beyond livid.
1 · Reply
Dsradoff720
Dsradoff720 Aug. 12 at 6:13 PM
$BRTX So this is something that does concern me (lender board nominee section) but the dates have come and gone already with no offering. Does that mean the board members automatically resigned as if the 10th? I think what happened is they got a waiver since the lender already controls the board. We would know by now if there was an offering consumated. It seems like the same language used in other contacts they had like shuttle pharmaceutical. This is such a wildcard stock lol it will either go to 0 or the moon!
2 · Reply
TheBigDawgRoman
TheBigDawgRoman Aug. 11 at 8:05 PM
$BRTX bag holding at 52
0 · Reply
Lyn30
Lyn30 Aug. 11 at 4:39 AM
$BRTX Every penny board one idiot is must 😂 . In this board one below 👇 😂. Resident bear I always block idiots
1 · Reply
Tuskdog
Tuskdog Aug. 10 at 5:46 PM
$BRTX so what’s the September date that they have to do a reverse split? 
1 · Reply
Lyn30
Lyn30 Aug. 10 at 5:14 PM
$BRTX This one may run big soon imo
1 · Reply
Zephix
Zephix Aug. 9 at 11:06 PM
$BRTX The company completed treatment administration in 99 patients in a randomized, double-blind, sham-controlled Phase 2 trial for chronic lumbar disc disease. Topline safety/efficacy data are expected in Q2 2027...
0 · Reply
MGroup
MGroup Aug. 3 at 9:56 PM
$BRTX it was all so positive for most of this year. Then the bottom dropped out. I'm ready to wrap up this "investment"
2 · Reply
Dsradoff720
Dsradoff720 Aug. 3 at 3:14 PM
$BRTX we need some bombshell good news dropped soon!
1 · Reply
TheBigDawgRoman
TheBigDawgRoman Jul. 31 at 4:04 PM
$BRTX lol
0 · Reply
Tuskdog
Tuskdog Jul. 31 at 2:52 PM
$BRTX took a loss and got out at $.30. Gotta wait about 25 more days, but I will be getting back in. 
2 · Reply
k3vl4r
k3vl4r Jul. 28 at 6:15 PM
K3vl4r AI outlook, Jul 28 Reading most bullish: $SOC $VEEE $OLB $BRTX Leaning bearish: $DFNS $DMRA $SHIB 1491/1804 tracked assets read bullish. Scenarios to research, not advice. https://app.k3vl4r.com/today #stocks #investing
0 · Reply
MGroup
MGroup Jul. 27 at 7:01 PM
$ISPC how good is Katharyn Field ? And what is she going to do for $BRTX ????
2 · Reply
MGroup
MGroup Jul. 27 at 6:42 PM
$BRTX Sure would like to hear from the new captain of the ship. We are nowhere close to being in compliance with Naz and another R/S should be criminal.
1 · Reply
Dsradoff720
Dsradoff720 Jul. 27 at 12:17 PM
$BRTX we have almost 10x normal premarket volume. I believe today’s premarket volume is close to exceeding last weeks regular open trade hour volume. I seeee a potentially biiiiig day 🤞🤞🤞🤞
1 · Reply
Dsradoff720
Dsradoff720 Jul. 27 at 12:10 PM
$BRTX 🤞🫡🇺🇸🫡
0 · Reply
Dsradoff720
Dsradoff720 Jul. 27 at 12:05 PM
$BRTX let’s start this week of strong! Big 21% spread but its current +7.76 premarket. With premarket highs of 11% and lows of -10%. Should be an exciting day one way or another!
2 · Reply
Dsradoff720
Dsradoff720 Jul. 24 at 7:07 PM
3 · Reply
Rahmmy
Rahmmy Jul. 24 at 5:34 PM
$BRTX I don't know if there's a bigger fool than @Dsradoff720 (who blocked me) thinking recent events are bullish. The Bowery Group just effectively bought control of this terrible company for $1 million. The entire management team that he was so bullish about is now gone. They want to raise $5 million to continue operations. Good luck with that while Alstodt and his pals are claiming $2.85 million in comp. I see this as a pending bankruptcy. Other than vendors, the Bowery Group is senior in the cap structure and will walk away with the IP, leaving nothing for the equity holders.
1 · Reply
jpurr
jpurr Jul. 23 at 12:29 AM
1 · Reply
Rahmmy
Rahmmy Jul. 22 at 5:19 PM
$BRTX Important to discuss what happened here IMHO : 1) Kaos bought 4.9% of this company and wanted it to pivot to AI. BRTX has no AI expertise or business. Companies during the .com boom did the same, adding the label to their company to attract unsophisticated buyers. That was a sham then and this feels like a sham now. 2) The Bowery Group agreed to a $1 million line in exchange for 3 board seats, gaining control of the company. Only a truly desperate, near bankrupt company would accept such a deal. This triggered what Lance Alstodt believed was a change of control (it did) and he, along with other execs, resigned and demanded $2.85 million in change of control comp. The new board plans to investigate how these deals were ever made. My guess is the company will file for BK unless they can raise $5 million, the stockholders will be left with zero, and Bowery will get the IP which has some value. No way they make that loan without access to the assets.
1 · Reply
Dsradoff720
Dsradoff720 Jul. 22 at 8:00 AM
$BRTX A good thing about this I just realized is the whole board now are the lenders people/selections. Which means we have direct access to getting capital I’d bet at great terms! $$$$$$$$
3 · Reply